Editas Medicine to Present Preclinical Data Demonstrating Advancements in In Vivo Gene Editing Approach for the Treatment of Genetic Ocular Diseases at the Association for Research in Vision and Ophthalmology Annual Meeting

Author's Avatar
May 01, 2021

Preclinical data support novel approaches for the treatment of Usher Syndrome 2A and retinitis pigmentosa 4